Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Quak

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Anticancer Research|July 1, 1996
Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancerG A van Dongen, R M Brakenhoff, C T ten Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
British Journal of Cancer|September 1, 1992
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgGM Gerretsen, A H Schrijvers, M van Walsum, et al.
Head & Neck|August 1, 1997
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complicationsM A van Bokhorst-de van der Schueren, P A van Leeuwen, H P Sauerwein, et al.
Cancer|August 3, 1999
The impact of nutritional status on the prognoses of patients with advanced head and neck cancervan Bokhorst-de van der Schuer, P A van Leeuwen, D J Kuik, et al.
AJNR. American Journal of Neuroradiology|October 30, 1999
Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancerM W van den Brekel, L C Reitsma, J J Quak, et al.
International Journal of Cancer|February 20, 1992
Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomasJ J Quak, H G Schrijvers, J G Brakkee, et al.
British Journal of Cancer|January 1, 1997
Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patientsR de Bree, J C Roos, M A Plaizier, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 1, 1996
Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancerG A van Dongen, R M Brakenhoff, C T ten Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
British Journal of Cancer|September 1, 1992
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgGM Gerretsen, A H Schrijvers, M van Walsum, et al.
Head & Neck|August 1, 1997
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complicationsM A van Bokhorst-de van der Schueren, P A van Leeuwen, H P Sauerwein, et al.
Cancer|August 3, 1999
The impact of nutritional status on the prognoses of patients with advanced head and neck cancervan Bokhorst-de van der Schuer, P A van Leeuwen, D J Kuik, et al.
AJNR. American Journal of Neuroradiology|October 30, 1999
Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancerM W van den Brekel, L C Reitsma, J J Quak, et al.
International Journal of Cancer|February 20, 1992
Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomasJ J Quak, H G Schrijvers, J G Brakkee, et al.
British Journal of Cancer|January 1, 1997
Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patientsR de Bree, J C Roos, M A Plaizier, et al.
Pageof 5